BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 29587847)

  • 1. High-sensitivity virus and mycoplasma screening test reveals high prevalence of parvovirus B19 infection in human synovial tissues and bone marrow.
    Watanabe K; Otabe K; Shimizu N; Komori K; Mizuno M; Katano H; Koga H; Sekiya I
    Stem Cell Res Ther; 2018 Mar; 9(1):80. PubMed ID: 29587847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence and significance of human parvovirus B19 DNA in synovial membranes and bone marrow from patients with arthritis of unknown origin.
    Cassinotti P; Siegl G; Michel BA; Brühlmann P
    J Med Virol; 1998 Nov; 56(3):199-204. PubMed ID: 9783685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for persistence of human parvovirus B19 DNA in bone marrow.
    Cassinotti P; Burtonboy G; Fopp M; Siegl G
    J Med Virol; 1997 Nov; 53(3):229-32. PubMed ID: 9365887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High frequency of parvovirus B19 DNA in bone marrow samples from rheumatic patients.
    Lundqvist A; Isa A; Tolfvenstam T; Kvist G; Broliden K
    J Clin Virol; 2005 May; 33(1):71-4. PubMed ID: 15797368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy.
    Söderlund M; von Essen R; Haapasaari J; Kiistala U; Kiviluoto O; Hedman K
    Lancet; 1997 Apr; 349(9058):1063-5. PubMed ID: 9107245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of parvovirus B19 in synovial fluid and bone marrow.
    Nikkari S; Roivainen A; Hannonen P; Möttönen T; Luukkainen R; Yli-Jama T; Toivanen P
    Ann Rheum Dis; 1995 Jul; 54(7):597-600. PubMed ID: 7668905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replicative multivirus infection with cytomegalovirus, herpes simplex virus 1, and parvovirus B19, and latent Epstein-Barr virus infection in the synovial tissue of a psoriatic arthritis patient.
    Mehraein Y; Lennerz C; Ehlhardt S; Zang KD; Madry H
    J Clin Virol; 2004 Sep; 31(1):25-31. PubMed ID: 15288610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of parvovirus B19 DNA in bone marrow of patients with haematological disorders.
    Lundqvist A; Tolfvenstam T; Brytting M; Stolt CM; Hedman K; Broliden K
    Scand J Infect Dis; 1999; 31(2):119-22. PubMed ID: 10447317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood.
    Lehmann HW; Knöll A; Küster RM; Modrow S
    Arthritis Rheum; 2003 Jun; 48(6):1631-8. PubMed ID: 12794831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Roche LightCycler parvovirus B19 quantification kit for the diagnosis of parvovirus B19 infections.
    Braham S; Gandhi J; Beard S; Cohen B
    J Clin Virol; 2004 Sep; 31(1):5-10. PubMed ID: 15288606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-permissiveness of synovial membrane cells to human parvovirus B19 in vitro.
    Miki NP; Chantler JK
    J Gen Virol; 1992 Jun; 73 ( Pt 6)():1559-62. PubMed ID: 1607873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent B19 parvovirus infection in pediatric malignancies.
    Broliden K; Tolfvenstam T; Ohlsson S; Henter JI
    Med Pediatr Oncol; 1998 Aug; 31(2):66-72. PubMed ID: 9680929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human parvovirus PARV4 DNA in tissues from adult individuals: a comparison with human parvovirus B19 (B19V).
    Corcioli F; Zakrzewska K; Fanci R; De Giorgi V; Innocenti M; Rotellini M; Di Lollo S; Azzi A
    Virol J; 2010 Oct; 7():272. PubMed ID: 20950445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of cytomegalovirus, human parvovirus B19, and herpes simplex virus-1/2 in women with first-trimester spontaneous abortions.
    Zhou Y; Bian G; Zhou Q; Gao Z; Liao P; Liu Y; He M
    J Med Virol; 2015 Oct; 87(10):1749-53. PubMed ID: 25976377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence, incidence of prenatal infections and reliability of maternal history of varicella zoster virus, cytomegalovirus, herpes simplex virus and parvovirus B19 infection in South-Western Finland.
    Alanen A; Kahala K; Vahlberg T; Koskela P; Vainionpää R
    BJOG; 2005 Jan; 112(1):50-6. PubMed ID: 15663397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parvovirus B19 infection in patients with rheumatoid arthritis in Taiwan.
    Chen YS; Chou PH; Li SN; Tsai WC; Lin KH; Tsai KB; Yen JH; Liu HW
    J Rheumatol; 2006 May; 33(5):887-91. PubMed ID: 16511938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of patients with arthritis and parvovirus B19 DNA in synovial membranes.
    Schmid S; Bossart W; Michel BA; Brühlmann P
    Rheumatol Int; 2007 Jun; 27(8):747-51. PubMed ID: 17401566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and laboratory findings in immunocompetent patients with persistent parvovirus B19 DNA in bone marrow.
    Lundqvist A; Tolfvenstam T; Bostic J; Söderlund M; Broliden K
    Scand J Infect Dis; 1999; 31(1):11-6. PubMed ID: 10381211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human parvovirus B19, varicella zoster virus, and human herpesvirus-6 in mesenchymal stem cells of patients with osteoarthritis: analysis with quantitative real-time polymerase chain reaction.
    Rollín R; Alvarez-Lafuente R; Marco F; Jover JA; Hernández-García C; Rodríguez-Navas C; López-Durán L; Fernández-Gutiérrez B
    Osteoarthritis Cartilage; 2007 Apr; 15(4):475-8. PubMed ID: 17207644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parvovirus B19 infection in children with acute lymphoblastic leukemia is associated with cytopenia resulting in prolonged interruptions of chemotherapy.
    Lindblom A; Heyman M; Gustafsson I; Norbeck O; Kaldensjö T; Vernby A; Henter JI; Tolfvenstam T; Broliden K
    Clin Infect Dis; 2008 Feb; 46(4):528-36. PubMed ID: 18194100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.